Felpreva

RSS

emodepside / praziquantel / tigolaner

Authorised
This medicine is authorised for use in the European Union.

Overview

Felpreva is an antiparasitic medicine used to treat cats that have, or that are at risk from, mixed parasitic infestations/infections (caused by more than one parasite). It contains the active substances tigolaner, emodepside and praziquantel.

This EPAR was last updated on 09/03/2022

Authorisation details

Product details
Name
Felpreva
Agency product number
EMEA/V/C/005464
Active substance
  • emodepside
  • praziquantel
  • Tigolaner
International non-proprietary name (INN) or common name
  • emodepside
  • praziquantel
  • tigolaner
Species
Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP52AA51
Publication details
Marketing-authorisation holder
Vétoquinol SA
Date of issue of marketing authorisation valid throughout the European Union
11/11/2021
Contact address
Magny-Vernois
F-70 200 Lure
France

Product information

Felpreva - EMEA/V/C/005464 -

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Anthelmintics

Therapeutic indication

For cats with, or at risk from, mixed parasitic infestations.

The veterinary medicinal product is exclusively indicated when ectoparasites, cestodes and nematodes are targeted at the same time.

Assessment history

How useful was this page?

Add your rating